Skip to main content Accessibility help
×
Hostname: page-component-7bb8b95d7b-fmk2r Total loading time: 0 Render date: 2024-10-04T00:29:54.677Z Has data issue: false hasContentIssue false

Section V - Mature Lymphoid Neoplasms

Published online by Cambridge University Press:  25 January 2024

Xiayuan Liang
Affiliation:
Children’s Hospital of Colorado
Bradford Siegele
Affiliation:
Children’s Hospital of Colorado
Jennifer Picarsic
Affiliation:
Cincinnati Childrens Hospital Medicine Center
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Woessmann, W, Quintanilla‐Martinez, L. Rare mature B‐cell lymphomas in children and adolescents. Hematological Oncology. 2019;37:5361.Google Scholar
Perkins, SL. Pediatric mature B-cell non-Hodgkin lymphomas. In: Proytcheva, MA, ed. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:395428.Google Scholar
Leoncini, L, Campo, E, Stein, H, et al. Burkitt lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:330–4.Google Scholar
Gascoyne, RD, Siebert, R, Connors, JM, et al. Burkitt’s lymphoma, and its mimics. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:447–64.Google Scholar
Dunleavy, K, Little, RF, Wilson, WH. Update on Burkitt lymphoma. Hematol Oncol Clin North Am. 2016;30:1333–43.Google Scholar
Ambrosio, MR, Navari, M, Di Lisio, L, et al. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infectious Agent Cancer. 2014;9:12.Google Scholar
Fish, K, Chen, J, Longnecker, R. Epstein-Barr virus latent membrane protein 2 A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma. Blood. 2014;123:530–40.Google Scholar
Navid, F, Mosijczuk, AD, Head, DR, et al. Acute lymphoblastic leukemia with the (8;14)(q24; q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia. 1999;13:135–41.Google Scholar
Gascoyne, R.D., Campo, E, Jaffe, ES, et al. Diffuse large B-cell Lymphoma, NOS. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press;2017:291–7.,Google Scholar
Chan, ACL, Chan, JKC. Diffuse large B-cell lymphoma. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:415–45.Google Scholar
Li, S, Young, KH, Medeiros, LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50:7487.CrossRefGoogle ScholarPubMed
Hu, S, Xu-Monette, ZY, Balasubramanyam, A, et al. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2013;121:2715–24.Google Scholar
Gaulard, P, Harris, NL, Pileri, SA, et al. Primary mediastinal (thymic) large B-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Rev. 4th ed. Lyon, France: IARC Press; 2017:314–6.Google Scholar
Martelli, M, Ferreri, A, Di Rocco, A, et al. Primary mediastinal large B-cell lymphoma. Crit Rev Oncol Hematol. 2017;113:318–27.Google Scholar
Oschlies, I, Burkhardt, B, Salaverria, I, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica. 2011;96:262–8.Google Scholar
Ott, G, Delabie, J, Gascoyne, RD, et al. T-cell/histiocyte-rich large B-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press; 2017:298–9.Google Scholar
Pittaluga, S, Jaffe, ES. T-cell/histiocyte-rich large B-cell lymphoma. Haematologica. 2010;95:352–6.Google Scholar
Nam-Cha, SH, Roncador, G, Sanchez-Verde, L, et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol. 2008;32:1252–7.Google Scholar
Hartmann, S, Döring, C, Vucic, E, et al. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Br J Haematol. 2015;169:415–22.Google Scholar
Jaffe, ES, Harris, NL, Swerdlow, SH, et al. Follicular lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al.. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:266–73.Google Scholar
Jaffe, ES, Harris, NL, Siebert, R. Pediatric-type follicular lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:278–9.Google Scholar
Ferry, JA, de Level, L, Louissaint, A Jr., et al. Follicular lymphoma. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:321–52.Google Scholar
Attarbaschi, A, Abla, O, Arias Padilla, L, et al. Rare non‐Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphoma. Pediatr Blood Cancer. 2020;67:e28416.Google Scholar
Liu, Q, Salaverria, I, Pittaluga, S, et al. Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol. 2013;37:333–43.Google Scholar
Pittaluga, S, Harris, NL, Siebert, R, et al. Large B-cell lymphoma with IRF4 rearrangement. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:280–1.Google Scholar
Sukswai, N, Lyapichev, K, Khoury, JD, et al. Diffuse large B-cell lymphoma variants: an update. Pathology. 2020;52:5367.Google Scholar
Campo, E, Pileri, SA, Jaffe, ES, et al. Nodal marginal zone lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:263–5.Google Scholar
Jaffe, ES. Nodal marginal zone lymphoma. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:383–96.Google Scholar
Attygalle, AD, Liu, H, Shirali, S, et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood. 2004;104:3343–8.CrossRefGoogle ScholarPubMed
Kluin, PM, Harris, NL, Stein, H, et al. High-grade B-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:335–41.Google Scholar
Sesques, P, Johnson, NA. Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements. Blood. 2017;129:280–8.Google Scholar
Kluin, PM, Harris, NL, Stein, H, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. 4th ed. Lyon, France: IARC Press; 2008:265–6.Google Scholar
Jaffe, ES, Stein, H, Swerdlow, SH, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:342–4.Google Scholar
Fend, F. Classical Hodgkin’s lymphoma and related lesions. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:525–45.Google Scholar
Sarkozy, C, Copie-Bergman, C, Damotte, D, et al. Gray-zone lymphoma between CHL and large B-cell lymphoma. Am J Surg Pathol. 2019;43:341–51.Google Scholar
Leoncini, L, Campo, E, Stein, H, et al. Burkitt-like lymphoma with 11q aberration. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.Lyon, France:IARC Press; 2017:334.Google Scholar
Salaverria, I, Martin-Guerrero, I, Wagener, R, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood. 2014;123:1187–98.Google Scholar

References

Macon, WR. Peripheral T-cell lymphomas. Hematopathology. 2018;1:306–39.Google Scholar
Perkins, SL. Pediatric mature T-cell and NK-cell non-Hodgkin lymphomas. In: Proytcheva, MA, eds. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:429–64.Google Scholar
Attarbaschi, A, Abla, O, Arias Padilla, L, et al. Rare non‐Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphoma. Pediatric Blood Cancer. 2020;67:e28416.Google Scholar
Falini, B, Lamant-Rochaix, L, Campo, E, et al. Anaplastic large cell lymphoma, ALK-positive. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:413–8.Google Scholar
Lamant-Rochaix, L, Feldman, AL, Delsol, G, et al. Anaplastic large cell lymphoma, ALK positive and ALK negative. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:673–91.Google Scholar
Montes-Mojarro, IA, Steinhilber, J, Bonzheim, I, et al. The pathological spectrum of systemic anaplastic large cell lymphoma (ALCL). Cancers. 2018;10:107.Google Scholar
Dunphy, CH, DeMello, DE, Gale, GB. Pediatric CD56+ anaplastic large cell lymphoma: a review of the literature. Arch Pathol Lab Med. 2006;130:1859–64.Google Scholar
Duyster, J, Bai, RY, Morris, SW. Translocations involving anaplastic lymphoma kinase (ALK). Oncogene. 2001;20:5623–37.Google Scholar
Liang, X, Branchford, B, Greffe, B, et al. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol. 2013;35:e209–13.Google Scholar
Feldman, AL, Harris, NL, Stein, H, et al. Anaplastic large cell lymphoma, ALK-negative. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:418–21.Google Scholar
Lamant-Rochaix, L, Feldman, AL, Delsol, G, et al. Anaplastic large cell lymphoma, ALK positive and ALK negative. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:673–91.Google Scholar
Ferreri, AJ, Govi, S, Pileri, SA, et al. Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol. 2013;85:206–15.Google Scholar
Pileri, SA, Weisenburger, DD, Sng, I, et al. Peripheral T-cell lymphoma, NOS. In: Swerdlow, SH, Campo, E, Harris, NL, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:403–7.Google Scholar
de Level, L. Peripheral T-cell lymphoma, not otherwise specified. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:641–57.Google Scholar
Mellgren, K, Attarbaschi, A, Abla, O, et al. Non-anaplastic peripheral T cell lymphoma in children and adolescents – an international review of 143 cases. Ann Hematol. 2016;95:1295–305.Google Scholar
Iqbal, J, Weisenburger, DD, Greiner, TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115:1026–36.Google Scholar
Chan, JKC, Quintanilla-Martinez, L, Ferry, JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow, SH, Campo, E, Harris, NL, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:368–71.Google Scholar
Ko, YH, Chan, JKC, Quintanilla-Martinez, L. Virally associated T-cell and NK-cell lymphoma. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:565–98.Google Scholar
Gaulard, P, Jeffe, ES, Krenacs, L, et al. Hepatosplenic T-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:381–2.Google Scholar
Gaulard, P. Hepatosplenic T-cell lymphoma. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:631–9.Google Scholar
Belhadj, K, Reyes, F, Farcet, JP, et al. Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261–9.Google Scholar
Willemze, R, Paulli, M, Kadin, ME. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.. Lyon, France: IARC Press; 2017:392–6.Google Scholar
Kempf, W, Kerl, K, Mitteldorf, C. Cutaneous CD30-positive T-cell lymphoproliferative disorders – clinical and histopathologic features, differential diagnosis, and treatment. Semin Cutan Med Surg. 2018;37:24–9.Google Scholar
Kadin, ME, Kempf, W. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:731–45.Google Scholar
Jaffe, ES, Gaulard, P, Cerroni, L. Subcutaneous panniculitis-like T-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:383–5.Google Scholar
Cerroni, L. Primary cutaneous T-cell lymphomas: Rare subtypes. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:747–60.Google Scholar
Gaulard, P, Berti, E, Willemze, R, et al. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:401–2.Google Scholar
Beltraminelli, H, Leinweber, B, Kerl, H, et al. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol. 2009;31:317–22.Google Scholar
Quintanilla-Martinez, L, Ko, YH, Kimura, H, et al. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:355–63.Google Scholar
Ko, YH, Chan, JKC, Quintanilla-Martinez, L. Virally associated T-cell and NK-cell neoplasms. In: Jaffe, E, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier;2017:565–98.Google Scholar
Cohen, JI, Manoli, I, Dowdell, K, et al. Hydroa vacciniforme–like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites. Blood. 2019;133:2753–64.Google Scholar
Liu, Y, Ma, C, Wang, G, et al. Hydroa vacciniforme–like lymphoproliferative disorder: Clinicopathologic study of 41 cases. J Am Acad Dermatol. 2019;81:534–40.Google Scholar

References

Stein, H, Pileri, SA, Weiss, LM, et al. Hodgkin lymphomas: Introduction. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press; 2017:424–30.Google Scholar
Onciu, M. Hodgkin lymphomas. In: Proytcheva, MA, ed. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:465–83.Google Scholar
Jaffe, ES, Stein, H, Swerdlow, SH. Classic Hodgkin lymphomas. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.Lyon, France:IARC Press; 2017:435.Google Scholar
Fend, F. Classical Hodgkin’s lymphoma and related lesions. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:525–45.Google Scholar
Mathas, S, Hartmann, S, Küppers, R. Hodgkin lymphoma: pathology and biology. Seminars Hematol. 2016; 53(3):139–47.Google Scholar
Mack, TM, Cozen, W, Shibata, DK, et al. Concordance for Hodgkin’s disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med. 1995;332:413–9.Google Scholar
Horwitz, M, Wiernik, PH. Pseudoautosomal linkage of Hodgkin disease. Am J Hum Genet. 1999;65:1413–22.Google Scholar
Paltiel, O. Family matters in Hodgkin lymphoma. Leuk Lymphoma. 2008;49:1234–5.Google Scholar
Stein, H, Pileri, SA, MacLennan, KA, et al. Nodular sclerosis classic Hodgkin lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:435–7.Google Scholar
Weiss, LM, Poppema, S, Jaffe, E, et al. Mixed cellularity classic Hodgkin lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press; 2017:440.Google Scholar
Anagnostopoulos, I, Piris, MA, Isaacson, PG, et al. Lymphocyte-rich classic Hodgkin lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press; 2017:438–40.Google Scholar
Benharroch, D, Jaffe, E, Stein, H. Lymphocyte-depleted classic Hodgkin lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:441–2.Google Scholar
Ansell, SM. Hodgkin lymphoma: A 2020 update on diagnosis, risk‐stratification, and management. Am J Hematol. 2020;95:978–89.Google Scholar
Stein, H, Swerdlow, SH, Gascoyne, RD, et al. Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.Lyon, France:IARC Press; 2017:431–4.Google Scholar
Hartmann, S, Eichenauer, DA. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma. Pathology. 2020;52:142–53.Google Scholar
Fan, Z, Natkunam, Y, Bair, E, et al. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27:1346–56.Google Scholar
Boudová, L, Torlakovic, E, Delabie, J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood. 2003;102: 3753–8.Google Scholar
Franke, S, Wlodarska, I, Maes, B, et al. Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin’s lymphoma. Am J Pathol. 2002;161:1861–7.Google Scholar

References

Onciu, M, van Krieken, JH. Immunodeficiency-associated lymphoproliferative disorders. In: Proytcheva, MA, ed.Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:484503.Google Scholar
Shabani, M, Nichols, KE, Rezaei, N. Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders. Crit Rev Oncol Hematol. 2016;108:109–27.Google Scholar
Low, LK, Song, JY. B-cell lymphoproliferative disorders associated with primary and acquired immunodeficiency. Surg Pathol Clin. 2016;9:5577.Google Scholar
van Krieken, JH, Onciu, M, Elenitoba-Johnson, KSJ, et al. Lymphoproliferative diseases associated with primary Immune disorders. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.Lyon, France:IARC Press; 2017:444–8.Google Scholar
Aricò, M, Mussolin, L, Carraro, E, et al. Non‐Hodgkin lymphoma in children with an associated inherited condition: a retrospective analysis of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Pediatr Blood Cancer. 2015;62:1782–9.Google Scholar
O’Malley, DP, George, TI, Orazi, A, et al. Congenital immunodeficiency diseases. In: Benign and reactive conditions of lymph node and spleen. Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2009; 185227.Google Scholar
Said, J, Cesarman, E, Rosenwald, A, et al. Lymphomas associated with HIV infection. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press; 2017:449–52.Google Scholar
O’Malley, DP, George, TI, Orazi, A, et al. Viral lymphadenopathies. In: Benign and reactive conditions of lymph node and spleen. Washington, DC: American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2009;283326.Google Scholar
Swerdlow, SH, Webber, SA, Chadburn, A, et al. Post-transplant lymphoproliferative disorders. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press; 2017:453–62.Google Scholar
Swerdlow, S, Craig, FE. Iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:1013–29.Google Scholar
Kalinova, L, Indrakova, J, Bachleda, P. Post-transplant lymphoproliferative disorder. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009;153:251–7.Google Scholar
Liu, L, Zhang, X, Feng, S. Epstein-Barr virus-related post-transplantation lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018;24:1341–9.Google Scholar
Romero, S, Montoro, J, Guinot, M, et al. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Leuk Lymphoma. 2019;60:142–50.Google Scholar
Nelson, BP, Nalesnik, MA, Bahler, DW, et al. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol. 2000;24:375–85.Google Scholar
Gaulard, P, Swerdlow, SH, Harris, NL, et al. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.Lyon, France: IARC Press; 2017:462–4.Google Scholar
Rosh, JR, Gross, T, Mamula, P, et al. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn’s disease: a cautionary tale? Inflamm Bowel Dis. 2007;13:1024–30.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×